SupplyChain Sentinel

Policy Event Date: 2025-12-18

Per the Federal Register notice dated 2025-12-18, the U.S. is adjusting tariffs on products of Switzerland and Liechtenstein, explicitly including generic pharmaceuticals, their ingredients, and chemical precursors — and this is a tariff decrease, which reduces cross-border cost exposure rather than adding risk. As Bristol-Myers Squibb's 10-K discloses, the company has significant manufacturing operations in Switzerland (alongside the U.S., Puerto Rico, the Netherlands, and Ireland). Because BMY relies on Swiss-based manufacturing, any change to U.S.-Switzerland tariff treatment on pharmaceutical-related goods directly affects the cost structure of that supply chain. In this case, the change is favorable, potentially lowering import costs tied to BMY's Swiss operations, though the filing does not specify whether generics specifically are produced there. Flagged as medium severity: the policy is high-impact in scope, but the filing's disclosure is a general manufacturing-footprint statement rather than a specific generics-and-Switzerland dependency, so the direct financial benefit to BMY cannot be precisely quantified from the provided text.

Policy Event Date: 2025-12-18

The Federal Register notice describes a U.S. move to adjust (decrease) tariffs on certain Swiss and Liechtenstein-origin goods, explicitly including generic pharmaceuticals and their ingredients and chemical precursors. Merck's 10-K discloses that one of its principal research facilities outside the U.S. is located in Switzerland, indicating meaningful operational exposure to that country. While the filing text does not specify that Swiss operations produce generic drugs or precursors for U.S. import, the geographic overlap between the policy's target (Switzerland) and Merck's disclosed Swiss footprint means any tariff change on pharmaceutical-related goods from Switzerland could affect the cost or logistics of materials tied to Merck's Swiss operations. Given the policy is rated high severity by the Policy Agent but the filing link is based on general facility presence rather than an explicit supply-chain dependency, this is flagged as a medium-severity alert warranting further diligence on whether Merck's Swiss site sources or ships tariff-affected generic drug inputs.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US adjustment lowering tariffs on EU-origin generic pharmaceuticals and their ingredients/precursors as part of the US-EU reciprocal trade framework. While AbbVie is primarily a branded biologics maker rather than a generics producer, its 10-K discloses that a substantial share of its manufacturing footprint is concentrated in Ireland, an EU member state, with major sites in Clonshaugh, Cork, Sligo, and Westport. Any EU-related tariff policy shift affecting pharmaceutical trade flows between the EU and US is relevant to AbbVie given this geographic concentration, since changes to the tariff treatment of EU-origin pharmaceutical products and their inputs could affect the cost and competitive dynamics of goods moving from these Irish facilities into the US market. The policy event itself is rated high severity by the Policy Agent given its breadth (covering pharmaceuticals and precursors), but the match to AbbVie is indirect since the filing does not specify generics manufacturing or Ireland-to-US trade flows explicitly — it only confirms Ireland as a key production hub. This warrants monitoring rather than immediate action, as the direct commodity overlap (generics vs. biologics) is imperfect, but the shared EU/Ireland exposure makes this a pairing worth flagging for further diligence on how tariff-related trade rule changes could ripple into AbbVie's broader EU manufacturing and export strategy.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US adjustment lowering tariffs on EU-origin generic pharmaceuticals, their ingredients, and chemical precursors as part of the US-EU reciprocal trade framework. AbbVie's 10-K discloses a manufacturing site in Ludwigshafen, Germany, indicating the company sources or produces biologics-related manufacturing activity within the EU. While the policy specifically targets generic drugs rather than biologics, any tariff relief on EU-origin pharmaceutical products and their precursors reduces cross-border cost pressure for companies operating EU manufacturing sites like AbbVie's Germany facility. Because the filing confirms a concrete EU manufacturing presence but does not specify whether Ludwigshafen output falls under the generic-drug tariff schedule, the read-through is directional rather than a precise dollar-for-dollar match — a favorable but not fully confirmed exposure alignment.

Policy Event Date: 2025-09-25

The Federal Register notice describes a U.S. tariff adjustment (a decrease) affecting products of the European Union, explicitly including generic pharmaceuticals and their ingredients and chemical precursors. This matters for Bristol-Myers Squibb because its 10-K discloses significant manufacturing operations in Ireland, an EU member state, alongside other sites. While BMY's risk text does not specify which products are made in Ireland or confirm they are generics, any EU-origin pharmaceutical output—including ingredients or precursors—could be captured by this tariff change. A tariff decrease is generally favorable, potentially lowering import costs or easing supply-chain economics for goods manufactured in Ireland and shipped to the U.S. Given the policy event's high severity as assessed by the Policy Agent, and BMY's confirmed manufacturing footprint in the affected country, this pairing is a plausible cost-side tailwind worth monitoring, though the lack of product-level detail in the filing limits certainty on magnitude.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US adjustment (decrease) of tariffs on EU-origin products, explicitly including generic pharmaceuticals and their ingredients and chemical precursors, as part of the US-EU reciprocal trade framework. Bristol-Myers Squibb's 10-K discloses that it has significant manufacturing operations in the Netherlands, an EU member state, alongside other sites. Because BMY sources or manufactures pharmaceutical products and inputs from an EU country directly named in this tariff action, any change in EU-related tariff treatment for pharmaceuticals could affect the cost structure or competitive dynamics tied to its Netherlands operations. While the filing does not specify generics production or import/export flows at this facility, the geographic overlap between the policy's EU scope and BMY's disclosed Netherlands manufacturing footprint makes this a relevant, if not fully confirmed, exposure worth monitoring.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US-EU framework adjusting tariffs on products of the European Union, explicitly including generic pharmaceuticals and their ingredients and chemical precursors. Eli Lilly's 10-K discloses that its active ingredient manufacturing and finishing operations take place at sites including Ireland, an EU member state. Because Lilly sources API and finishing activity from Ireland, a tariff_decrease on EU-origin pharmaceutical ingredients per the Federal Register document could lower import costs or reduce trade friction for material flowing from these Irish sites into the US, as Lilly's own risk disclosure confirms this geographic dependency exists. Severity is rated medium: while the policy event itself is flagged high severity by the Policy Agent, the filing text describes ingredient manufacturing broadly across many global sites without specifying volumes or dollar exposure tied to Ireland specifically, so the direct financial impact on Lilly cannot be quantified from the text provided.

Policy Event Date: 2025-09-25

Per the Federal Register notice, the US-EU framework adjusts tariffs on EU-origin generic pharmaceuticals and their ingredients/precursors. As Pfizer's 10-K discloses, its Pharmaceutical Global Supply network includes a manufacturing plant in Germany among its 36 global sites, meaning products or inputs sourced from that facility could be directly affected by this tariff change. A tariff decrease would generally be a favorable development, potentially lowering import costs or improving competitiveness for goods moved between the EU and US tied to this manufacturing footprint. Because the filing confirms an active Germany-based production site within the same EU jurisdiction named in the policy, this is a direct geographic match, though the filing does not specify which products at that site are generics or precursor-dependent, tempering the certainty of the impact.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US tariff adjustment (decrease) affecting EU-origin products, explicitly including generic pharmaceuticals and their ingredients and chemical precursors. Pfizer's 10-K discloses that its Pharmaceutical Global Supply (PGS) network includes a manufacturing plant in Ireland, an EU member state, among its 36 global sites producing products for its commercial divisions. Because Ireland-based production would fall under the EU-origin scope referenced in the tariff snippet, any change to US tariffs on EU pharmaceutical goods and their precursors could directly affect the cost structure or trade flow of products manufactured at Pfizer's Irish facility. While the policy event itself is rated high severity due to its broad framework nature, the filing only generically lists Ireland among several manufacturing locations without specifying volume, product mix, or reliance level, so the direct financial impact on Pfizer specifically is less certain. This warrants monitoring as a moderate-priority signal rather than an immediate high-impact alert.

Policy Event Date: 2025-09-25

Per the Federal Register notice, the U.S. is adjusting tariffs on EU-origin products, explicitly including generic pharmaceuticals and their ingredients and chemical precursors, as part of the U.S.-EU reciprocal trade framework. As Viatris' 10-K discloses, the company's significant manufacturing, packaging, warehousing and distribution activities are located primarily in the U.S., Puerto Rico, Singapore, India, Australia, China, and certain EU countries, including Ireland — a key EU manufacturing hub for the company. Because Viatris relies on EU-based (Irish) manufacturing that would fall under the scope of this tariff adjustment on generic drugs and their ingredients, a tariff decrease could reduce input costs or import friction for products and components sourced from or shipped through Ireland. While this is a favorable directional change rather than a new risk, the direct overlap between the policy's affected product category and Viatris' disclosed EU manufacturing footprint makes this a notable link for margin and supply-chain cost analysis, warranting a medium severity flag given the high-severity nature of the underlying policy shift but the currently limited specificity on dollar or volume impact in the filing.

Policy Event Date: 2026-06-24

The US has initiated a Section 301 investigation into Germany's persistent underpayment for innovative pharmaceutical products, per the Federal Register notice, signaling potential trade friction or retaliatory measures tied to how Germany prices and reimburses innovative drugs. This matters directly for AbbVie, whose 10-K discloses a biologics manufacturing presence in Ludwigshafen, Germany. Any outcome from the investigation—whether new trade measures, pricing reforms, or diplomatic escalation—could affect the operating environment for AbbVie's German manufacturing footprint, including regulatory treatment, market access, or cost dynamics for products made there. While the policy action is still at the investigation stage and no specific tariffs or penalties have been announced, the direct geographic overlap between the policy target and AbbVie's disclosed manufacturing site warrants monitoring.

Policy Event Date: 2026-06-24

A Section 301 investigation has been initiated against Germany over its persistent underpayment for innovative pharmaceutical products, per the Federal Register notice. This matters for Pfizer because, as Pfizer's 10-K discloses, its Pfizer Global Supply (PGS) network includes a manufacturing plant in Germany among its 36 sites worldwide producing commercial products. Any trade action, retaliatory tariff, or pricing remedy stemming from this investigation could directly affect the economics of Pfizer's German manufacturing operations and the products they supply, given the filing's explicit acknowledgment of German-based production. While the investigation is still in an early, exploratory phase (hearings and comment requests) and its ultimate scope and remedies remain undefined, the direct overlap between the targeted country and commodity in the policy action and Pfizer's disclosed manufacturing footprint warrants monitoring for supply-chain or cost impacts.

Policy Event Date: 2025-12-29

The Federal Register notice describes a new U.S. responsive tariff action on semiconductors from China, starting at 0 percent and increasing over an 18-month period, targeting China's practices related to the semiconductor sector. While this action is framed as a tariff on Chinese semiconductor imports rather than U.S. equipment exports, it signals escalating trade friction in the exact bilateral semiconductor relationship where Applied Materials already has flagged risk. AMAT's 10-K discloses that U.S. export controls restrict its ability to sell certain technologies to customers in China, showing the company's business is already sensitive to shifts in U.S.-China semiconductor policy. A new tariff measure targeting China's semiconductor practices adds another layer of regulatory uncertainty to this same country and sector, raising the risk of further restrictions, retaliation, or supply-chain disruption that could compound the export-control exposure AMAT has already identified. The link is thematically strong (same country, same sector) but not a direct hit on AMAT's specific disclosed risk, warranting medium rather than high severity.

Policy Event Date: 2025-12-29

The Federal Register notice announces a responsive tariff action on semiconductors from China, starting at 0 percent and increasing over 18 months, specifically targeting China's practices around advanced logic chips. While Lam Research's 10-K does not discuss tariffs directly, it explicitly flags China as a significant region for sales and warns that this exposure has already been impacted and is likely to be materially and adversely affected by export license requirements and other regulatory changes. This pairing matters because a new US tariff mechanism aimed at Chinese semiconductor activity adds another layer of regulatory pressure on the same US-China semiconductor trade relationship that Lam Research has already identified as a material risk to its business. Even though the filing centers on export licenses rather than tariffs specifically, the underlying dependency — Lam's reliance on China as a customer base amid tightening US policy — is the same dependency the tariff action targets, making the company's China-linked revenue more vulnerable to compounding regulatory actions over time.

Policy Event Date: 2025-12-29

The Federal Register notice describes a US tariff action targeting semiconductors from China, starting at 0 percent and increasing over 18 months, in response to China's acts and practices related to the semiconductor sector. Micron's 10-K discloses that it operates its own manufacturing facilities in China, among other countries, as part of its global production footprint. While the policy snippet references semiconductors broadly rather than memory chips specifically, and the tariff phase-in gives time to adjust, the direct overlap between the country named in the tariff action and Micron's disclosed China manufacturing presence means any escalation in US-China semiconductor tariff measures could raise costs or complicate supply chains for output produced at Micron's China facilities. Given the gradual tariff ramp and the fact that Micron's disclosure covers general manufacturing presence rather than a specific dependency tied to advanced logic chips, this is flagged as a medium-severity watch item rather than an immediate high-impact concern.

Policy Event Date: 2024-12-30

The federal government has initiated a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, per the Federal Register notice dated 2024-12-30. This regulatory scrutiny directly concerns the U.S.-China semiconductor relationship that Applied Materials (AMAT) already identifies as a key risk factor. As AMAT's 10-K discloses, the company faces export controls established by the U.S. government restricting the sale of certain technologies to customers in China. An investigation aimed at countering China's semiconductor ambitions could lead to further export restrictions or retaliatory measures, compounding the existing regulatory risk AMAT has flagged around its China-related equipment sales. While the investigation itself does not specify new rules or penalties yet, its focus on the same U.S.-China semiconductor policy dynamic that AMAT cites as a material risk warrants monitoring for potential escalation.

Policy Event Date: 2024-12-30

The Federal Register notice describes a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, signaling potential U.S. regulatory or trade action affecting China-linked chip supply chains. Intel's 10-K discloses that in 2025 its key assembly and test facilities were located in China, alongside New Mexico, Vietnam, and Malaysia, meaning a meaningful part of Intel's back-end manufacturing footprint sits inside the jurisdiction now under scrutiny. While Intel's advanced packaging capacity is being built out in New Mexico and Malaysia, the continued reliance on Chinese assembly and test operations, as Intel's 10-K discloses, means any policy response stemming from the investigation referenced in the Federal Register notice could directly affect Intel's China-based operations. Given the investigation is still in an early, exploratory phase (hearing and public comment stage) rather than an enacted rule, the immediate risk is moderate but warrants monitoring as it could escalate into tariffs, export controls, or other restrictions impacting Intel's China assembly and test capacity.

Policy Event Date: 2024-12-30

The U.S. government has initiated a Section 301 investigation into China's acts, policies, and practices aimed at achieving dominance in the semiconductor industry, per the Federal Register notice, with advanced logic chips specifically named as an affected product. This signals a heightened risk of new regulatory or trade actions targeting China's chip sector. Lam Research's 10-K already discloses that its sales to customers in China—a significant region for the company—have been impacted and are likely to be materially and adversely affected by export license requirements and other regulatory changes. Because Lam Research supplies fab equipment used in advanced semiconductor manufacturing, any escalation stemming from this investigation (e.g., new export controls or licensing restrictions) could directly worsen the exact China-related regulatory risk the company has flagged. The link is directional but not yet definitive, as the investigation is still in its early hearing/comment stage, warranting a medium severity rating.

Policy Event Date: 2024-12-30

The Federal Register notice describes a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, a medium-severity regulatory action focused on advanced logic chips. While Micron's core exposure is memory chips rather than logic, its 10-K discloses that the company manufactures products within its own facilities located in China, among other countries. This direct manufacturing presence in China means Micron could be exposed to any retaliatory measures, export controls, or operational disruptions that could arise from an escalating Section 301 investigation targeting China's semiconductor sector broadly. Because the filing confirms an active operational footprint in the very country under regulatory scrutiny, the pairing warrants monitoring even though the investigation's stated product focus (advanced logic) differs from Micron's memory chip business.

Policy Event Date: 2024-12-30

The Federal Register notice shows the U.S. government has initiated a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, specifically covering advanced logic chips. This regulatory scrutiny directly overlaps with NVIDIA's own risk disclosure, in which its 10-K discloses that it 'has been subject to a series of shifting and expanding export control restrictions, impacting our ability to serve customers outside the United States,' including licensing requirements affecting exports to China dating back to August 2022. Because NVIDIA's filing already flags China-related export control exposure as a material risk, an active Section 301 investigation into China's semiconductor practices signals potential for further regulatory action (e.g., new restrictions, tariffs, or retaliatory measures) that could compound NVIDIA's existing compliance burden and China revenue exposure. The policy action itself is only at the investigation stage (no new rule yet), and NVIDIA's disclosure is a generic ongoing risk factor rather than a specific reaction to this probe, so the severity is assessed as medium rather than high.

Policy Event Date: 2024-12-30

The Federal Register notice announces a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, with advanced logic chips specifically flagged. This matters for Qualcomm because its 10-K already discloses that Chinese tariffs on its integrated circuit products, or on devices incorporating them, could make those products more expensive for Chinese customers and consumers. In other words, the exact trade friction the U.S. government is now formally investigating is a risk Qualcomm has pre-identified as material to its China-exposed business. If this investigation leads to retaliatory tariffs or new trade restrictions, it would directly intersect with the vulnerability Qualcomm's own filing highlights, making the policy action a credible near-term threat rather than a speculative one. Severity is rated medium because, per the policy source, this is still an investigation (not an enacted tariff or export control), but the direct overlap with Qualcomm's disclosed China/tariff risk in its 10-K warrants close monitoring.

Policy Event Date: 2024-12-30

The Federal Register notice announces a Section 301 investigation into China's acts, policies, and practices targeting the semiconductor industry for dominance, signaling potential future trade actions affecting advanced logic chips. Texas Instruments' 10-K discloses that revenue from end customers headquartered in China was about 20% of 2025 revenue, while revenue from products shipped into China was about 50% of 2025 revenue. Given this scale of China-linked revenue, any regulatory or trade measures stemming from the Section 301 investigation could materially affect TXN's business, making this policy-filing pairing directly relevant to investors monitoring China-related supply chain and trade risk.

Policy Event Date: 2024-12-05

The Federal Register notice adds entities tied to advanced-node integrated circuit and semiconductor manufacturing development to the Entity List, signaling tightening U.S. export controls affecting China-linked advanced chip supply chains. Intel's 10-K discloses that one of its key assembly and test facilities in 2025 was located in China, alongside sites in New Mexico, Vietnam, and Malaysia. While Intel's filing does not specify advanced-node production at the China site itself, the company's reliance on China as part of its global assembly and test footprint means any escalation in U.S.-China export restrictions on advanced logic chips could create compliance, logistics, or operational friction for Intel's China-based operations. The severity is rated medium because the policy action is high-impact and squarely targets advanced chip supply chains, but the filing text shows China plays a secondary role relative to Intel's other packaging hubs, tempering the directness of the exposure.

Policy Event Date: 2024-12-05

The Federal Register notice from December 2024 expands the U.S. Entity List to capture entities involved in developing and producing advanced-node integrated circuits and related semiconductor manufacturing items, an action the Policy Agent rates high severity given its direct targeting of advanced chip production and equipment. Micron's 10-K discloses that it operates manufacturing facilities in China alongside other countries, meaning any tightening of export controls or entity-list restrictions tied to Chinese semiconductor operations could touch Micron's own production footprint or its supply chain for equipment and components used there. While the policy snippet does not specifically name Micron or memory chips, and Micron's disclosure is a general list of manufacturing locations rather than a specific dependency on advanced-logic export flows, the overlap in country and semiconductor manufacturing scope is a relevant risk factor for investors to monitor, particularly if enforcement actions expand toward memory or broader fab equipment categories. This warrants medium severity: the policy action itself is significant, but the filing text shows only a geographic overlap rather than an explicit, direct exposure to the exact restricted items.

Policy Event Date: 2023-10-17

The Federal Register notice describes BIS revising Validated End-User authorizations for Samsung China Semiconductor and SK hynix in China, a high-severity regulatory tightening around memory chip operations in-country. While the policy directly names Samsung and SK hynix rather than Intel, it signals broader U.S. export-control scrutiny over China-based semiconductor manufacturing activity. Intel's 10-K discloses that in 2025 its key assembly and test facilities were located in China, New Mexico, Vietnam, and Malaysia, confirming that China remains part of Intel's core chip packaging and testing footprint. Given this overlap in country and semiconductor supply-chain function, escalating VEU-related regulatory actions in China could foreshadow similar compliance or operational risk for other chipmakers, including Intel, operating assembly and test facilities there. Severity is rated medium because the policy event is high-severity but targets named competitors rather than Intel directly, while Intel's filing confirms a plausible but not identical dependency.

Policy Event Date: 2023-10-17

The Federal Register notice describes BIS amending export control authorizations (the Validated End-User list) specifically for Samsung China Semiconductor and SK hynix Semiconductor in China, a high-severity regulatory change affecting memory chip operations in that country. While the policy action targets Micron's competitors rather than Micron directly, it signals that Washington is actively tightening and adjusting the terms under which memory chip makers can operate manufacturing facilities in China. This matters for Micron because, as Micron's own 10-K discloses, the company 'manufacture[s] our products within our own facilities located in ... China,' meaning Micron shares the same operating environment and regulatory exposure as the VEU-list companies named in the policy. Any shift in how BIS treats validated end-user status for memory chip manufacturers in China raises the risk that similar scrutiny, licensing requirements, or restrictions could eventually extend to or indirectly affect Micron's China-based operations, given the shared country and commodity dependency flagged in both the policy snippet and Micron's risk disclosure. Investors should watch for follow-on BIS actions or export rule changes that could affect Micron's ability to operate its China facility.

Policy Event Date: 2023-10-17

BIS's revision of Validated End-User authorizations for Samsung China Semiconductor and SK hynix in China signals tightening U.S. export-control oversight over chip operations in China, per the Federal Register notice. While the policy targets memory chip VEU status rather than Qualcomm directly, it underscores heightened regulatory friction around semiconductor trade with China at a time when Qualcomm's 10-K already discloses that Chinese tariffs on its integrated circuit products or devices incorporating them could raise costs for Chinese customers and consumers. The shared country context (China) and semiconductor supply-chain linkage mean escalating U.S.-China regulatory actions of this kind could compound the trade-policy risks Qualcomm has flagged, even though the specific commodity (memory vs. advanced logic chips) differs. Severity is rated medium given the high-severity nature of the underlying regulatory shift but only an indirect, sector-level match to Qualcomm's disclosed risk.

Policy Event Date: 2023-10-17

The Federal Register notice shows BIS revising Validated End-User authorizations in China specifically for Samsung China Semiconductor and SK hynix, tightening export control oversight on memory chip operations in China. While this action targets memory chip makers rather than TXN directly, it signals an escalating U.S. regulatory posture toward semiconductor operations tied to China, a dynamic that matters for any chipmaker with heavy China exposure. As Texas Instruments' 10-K discloses, China accounted for about 20% of revenue by customer headquarters and roughly 50% of revenue by shipment destination in 2025, making TXN highly sensitive to any broadening of export control or VEU-related restrictions in the region. If BIS's regulatory tightening extends beyond memory chips to other semiconductor categories or VEU participants, TXN's outsized reliance on China-linked revenue—per its own risk disclosure—could face compliance, supply chain, or demand disruptions. The direct product overlap (memory vs. advanced logic chips) is not exact, which tempers severity, but the shared regulatory theme and TXN's substantial China revenue concentration justify a medium-severity watch flag for portfolio managers tracking U.S.-China semiconductor policy risk.

Policy Event Date: 2024-09-18

The Federal Register notice indicates a proposal to raise tariffs on wafers (among other products) from China, rated high severity by the Policy Agent. While Applied Materials' 10-K does not discuss tariffs directly, it does flag China as a key risk area, disclosing that U.S. export controls already restrict its ability to sell certain technologies to Chinese customers. Together, these signals point to compounding pressure on AMAT's China-related business: the federal register policy suggests import costs for China-origin wafers could rise, and this comes at a time when AMAT's own filing shows its China operations are already constrained by export control risk. For a portfolio manager, this means AMAT's China revenue stream faces layered regulatory risk — from both the demand side (export controls limiting sales) and now potentially the supply/cost side (tariffs on wafers), even though the filing does not explicitly address tariffs itself. The overlap in country focus (China) and the semiconductor supply chain relevance (wafers vs. semiconductor manufacturing equipment) makes this a relevant, though indirect, risk correlation worth monitoring.

Policy Event Date: 2024-09-18

The Federal Register notice describes a proposed increase in tariff rates on certain tungsten products, wafers, and polysilicon originating from or related to China, a high-severity trade action targeting core semiconductor inputs. Intel's 10-K discloses that one of its key assembly and test facilities is located in China, alongside sites in New Mexico, Vietnam, and Malaysia. While the filing does not specify wafer sourcing details, wafers are a foundational input to the chip packaging and testing operations Intel conducts in China, meaning higher tariffs on wafers could raise input costs or complicate supply chains at this facility. Because Intel maintains a direct operational footprint in China but is also diversifying into Malaysia, the exposure is real but partially mitigated, warranting a medium severity rating.

Policy Event Date: 2024-09-18

Per the Federal Register notice, China is proposing to increase tariff rates on certain tungsten products, wafers, and polysilicon, a direct cost pressure on semiconductor manufacturing inputs. As Micron's 10-K discloses, the company manufactures its products within its own facilities located in several countries including China, meaning any wafer-related tariff increase in China could raise input or production costs at that specific manufacturing site. While the filing does not quantify China's share of Micron's wafer processing or output, the geographic overlap between the policy's target commodity and Micron's disclosed China operations is a direct match worth monitoring, particularly given the high severity assigned to this tariff action.

Policy Event Date: 2024-09-18

The Federal Register notice describes a proposed increase in Chinese tariff rates on wafers (among other tech inputs), a high-severity policy shift given wafers' role as the base material for chip manufacturing. NVIDIA's 10-K already discloses that it operates under 'shifting and expanding export control restrictions' affecting its ability to serve customers in China, including licensing requirements tied to advanced logic chips. While the tariff action concerns wafers rather than the finished logic chips NVIDIA sells, both sit within the same China-linked semiconductor supply chain that NVIDIA's own risk factors flag as a source of regulatory uncertainty. This pairing matters because it shows policy pressure building on multiple fronts of the same value chain NVIDIA has identified as exposed to China-related trade friction, reinforcing the credibility of the company's disclosed risk rather than introducing a wholly new one.

Policy Event Date: 2023-10-25

The Federal Register notice (10/25/2023) documents that the U.S. government further restricted China's access to advanced computing items, including advanced logic chips, citing national security concerns tied to modernizing military capabilities. Intel's 10-K discloses that in 2025 one of its key assembly and test facilities was located in China, alongside other sites in New Mexico, Vietnam, and Malaysia. While the filing does not specify advanced logic chip production at the China site, the overlap between the U.S. export-restriction regime targeting advanced computing/logic chips and Intel's continued reliance on a China-based assembly and test facility creates exposure: any tightening of controls on technology flows to or from China could affect operations, supply continuity, or compliance obligations at that facility. Given the high severity of the policy action and the direct geographic overlap disclosed in Intel's own risk factors, this pairing warrants portfolio attention, though the filing does not confirm the China facility handles the specific advanced logic chips named in the policy, tempering the severity to medium.

Policy Event Date: 2023-10-25

The U.S. Federal Register notice describes new export controls restricting China's access to advanced computing and semiconductor technologies for national security reasons, a policy rated high severity given its direct targeting of advanced logic chip technology flows to China. Micron's 10-K discloses that it operates manufacturing facilities located in China, among other countries, meaning any escalation of U.S.-China export restrictions could directly affect Micron's China-based operations, supply chain logistics, or ability to service customers there. While the policy specifically targets advanced logic chips and Micron's disclosed exposure is framed around memory chip manufacturing rather than logic chips, the shared China nexus and the broad national-security rationale behind the export controls mean Micron's on-the-ground China presence puts it within the zone of regulatory risk. Investors should watch for potential knock-on effects if controls expand to cover memory or adjacent technologies, or if China responds with retaliatory measures affecting foreign manufacturers operating within its borders.

Policy Event Date: 2025-09-02

The Federal Register notice describes a high-severity U.S. action revoking Validated End-User authorizations for Intel Semiconductor (Dalian), Samsung China Semiconductor, and SK hynix Semiconductor (China), which will constrain memory chip operations in China and likely trigger retaliatory or compensatory friction in the China semiconductor trade channel. While Qualcomm is not named in the policy snippet, its 10-K already discloses that Chinese tariffs on its integrated circuit products or on devices incorporating them make those products more expensive for Chinese customers and consumers, per Qualcomm's 10-K. This shows Qualcomm has a pre-existing, disclosed exposure to China-related trade actions affecting semiconductor products, so escalating U.S.-China restrictions in this sector—even when centered on other firms' VEU status—raise the risk that similar tariff or export friction could extend to Qualcomm's China business, as flagged in its own filing. Severity is set to medium because the policy event does not directly name Qualcomm or its specific product category (advanced logic chips vs. memory chips), but the shared China semiconductor trade-restriction theme and Qualcomm's explicit tariff risk disclosure warrant investor attention.

Policy Event Date: 2025-09-02

The Federal Register notice revokes Validated End-User authorizations for Intel, Samsung, and SK hynix semiconductor units in China, tightening U.S. export controls on memory chip operations there. While Texas Instruments is not named in the policy action, its own 10-K discloses that products shipped into China made up about 50% of 2025 revenue and China-headquartered customers about 20%, underscoring how concentrated TXN's business is in the same country now facing escalating export-control enforcement. Even though this specific action targets memory-chip VEU status rather than TXN's logic chip lines, it signals a broader U.S. regulatory tightening trend on China-based semiconductor operations. Given TXN's disclosed reliance on China-linked revenue streams, further export restrictions or VEU-style revocations could pose downstream risk to its supply chain or customer access, warranting continued monitoring even though the direct product overlap is not explicit in the provided text.

Policy Event Date: 2026-03-17

The Federal Register notice announces Section 301 investigations into structural excess capacity in economies including China, specifically citing textiles and fabric as an affected product category. Columbia Sportswear's 10-K already discloses meaningful reliance on China-based manufacturing, noting that finished goods manufacturers in China produced approximately 10% of its products (with Vietnam, another named economy in the same investigation, producing about 80%). While China is not the dominant sourcing country for Columbia per the filing, its inclusion in both the policy action and the company's disclosed supply chain means any resulting tariff increases on textiles from China could directly raise input costs or force sourcing shifts for a portion of Columbia's production. The medium severity reflects that this is an investigation stage rather than an enacted tariff, but the direct overlap between the named country/product in the policy source and Columbia's own risk disclosure warrants monitoring for escalation.

Policy Event Date: 2026-03-17

The Federal Register notice describes newly initiated Section 301 investigations into structural excess capacity in several economies, explicitly naming China, as a precursor to potential tariff action on textiles and fabric. Crocs' 10-K discloses that prior to 2025, the majority of its HEYDUDE Brand production was based in China, indicating a direct historical manufacturing dependency on the country under scrutiny. While Crocs' filing suggests this concentration existed 'prior to 2025' (implying some diversification may already be underway), any resulting tariff increase from the investigation could still affect residual China-based production costs or transition timelines for HEYDUDE. Given the investigation is still in its early, exploratory phase per the policy source, and the filing text hints at reduced current reliance, this is flagged as medium severity rather than high.

Policy Event Date: 2026-03-17

The Federal Register notice announces Section 301 investigations targeting economies—including China—flagged for structural excess capacity in textiles and fabric, which could lead to new tariffs or trade restrictions on Chinese textile-related imports. Levi Strauss's 10-K already identifies this exact exposure, disclosing that risks affecting 'the sourcing and availability of raw materials, including cotton, used by our suppliers' and 'the importation of products from China into the United States' could impact its business. Because the policy action and the filed risk both center on China and textile/cotton-related sourcing, any escalation from this investigation into tariffs would directly touch a dependency Levi's has already flagged as material, making this a pairing worth monitoring rather than an abstract macro risk.

Policy Event Date: 2026-03-17

The Federal Register notice describes the initiation of Section 301 investigations targeting economies with structural excess capacity in textiles and fabric, explicitly naming China among the countries under review. PVH Corp's 10-K already discloses a material China-specific risk unrelated in origin but overlapping in geography: its placement on China's Ministry of Commerce List of Unreliable Entities, which carries the risk of fines or restrictions that could limit PVH's ability to do business in China. While the policy action concerns U.S. tariff exposure on Chinese textile imports and the filing risk concerns Chinese regulatory retaliation against PVH, both point to the same underlying vulnerability: PVH's business is highly exposed to shifting U.S.-China trade and regulatory friction. An escalation in tariffs per the Section 301 investigation could coincide with or amplify Beijing's willingness to use tools like the Unreliable Entities List against U.S. apparel companies, compounding PVH's disclosed China-related operational risk. This is a medium-severity signal because the tariff action is still at the investigation stage, but the direct overlap in country and sector (textiles/apparel) with PVH's already-flagged China dependency warrants monitoring.

Policy Event Date: 2025-12-04

The Federal Register notice describes a tariff decrease on automobiles and automobile parts under the US-Korea Strategic Trade and Investment Deal, amending the tariff treatment set out in Proclamation 10908. This is a high-severity policy shift specifically targeting the auto parts trade lane with South Korea. BorgWarner's 10-K discloses that approximately 6% of its sourcing originated in South Korea, indicating a direct, quantified dependency on the exact country and commodity category affected by this tariff change. While a tariff decrease is generally a tailwind rather than a risk, it signals that Korea-linked auto parts costs and trade terms are actively being renegotiated at the government level, which could affect BorgWarner's input costs, sourcing strategy, and competitive positioning versus peers with different geographic supply chains. Given the direct overlap between the policy's scope and BorgWarner's disclosed Korea exposure, portfolio managers should monitor how this tariff adjustment flows through to BorgWarner's margins and supplier relationships.

Policy Event Date: 2025-09-16

The U.S.-Japan agreement, per the Federal Register notice, adjusts (decreases) duties on Japanese automobiles and automobile parts previously imposed under Proclamation 10908, a change the Policy Agent rates high severity given its broad scope over Japan-origin auto trade. As Adient's 10-K discloses, the company operates manufacturing and other facilities in Japan (listed among its country-by-country facility counts alongside the U.S., Mexico, Germany, and others), confirming Adient has real operational exposure to Japan as an auto parts supply-chain node. While the filing does not quantify revenue or cost impact from Japan specifically, the fact that Adient maintains a physical presence there means any tariff-related cost changes on Japanese automobiles/auto parts could affect input costs, intercompany shipments, or competitive dynamics for Adient's Japan-based operations. Because the policy is a decrease (easing) rather than a new restriction, the immediate risk is lower, but portfolio managers should watch for second-order effects on regional sourcing decisions and margin shifts tied to this Japan-U.S. auto tariff realignment.

Policy Event Date: 2025-09-16

The Federal Register notice implements tariff-related elements of the US-Japan agreement, reducing duties on Japanese automobiles and automobile parts that had been subject to Proclamation 10908. This is a high-severity policy shift given autos/parts were previously targeted for tariff increases. BorgWarner's 10-K discloses a direct exposure to this exact product-country pairing: its NSK-Warner K.K. joint venture, which manufactures transmission components, is 50% owned and based in Japan/China alongside partner NSK Ltd. Since NSK-Warner's transmission components fall squarely under the automobile parts category covered by the tariff change, a decrease in duties on Japanese auto parts could lower input or production costs tied to this joint venture, modestly benefiting BorgWarner's cost structure or competitive positioning in this segment. The match between the policy's product scope and BorgWarner's disclosed Japan-based parts operation is direct, though the JV is only partially owned and represents one of several international manufacturing relationships, warranting a medium severity rating.

Policy Event Date: 2025-09-25

Per the Federal Register notice on implementing the US-EU framework agreement, automobiles and automobile parts covered under Proclamation 10908 are subject to a tariff decrease as part of the reciprocal tariff arrangement between the US and EU. This is a high-severity policy shift because it directly alters the cost structure for auto parts trade flows between the two economies. As Adient's 10-K discloses, the company maintains a notable manufacturing and facility footprint in Germany, listed among its key country-level operational exposures alongside the US, Mexico, and other manufacturing hubs. Since Adient is a major auto parts supplier with EU-based (specifically German) operations feeding into transatlantic automotive supply chains, a reduction in tariffs on automobiles and automobile parts under this US-EU framework could ease cost pressures or alter competitive dynamics for Adient's cross-border parts flows. While the filing does not quantify direct tariff exposure, the geographic alignment between the policy's scope (EU automobiles/parts) and Adient's disclosed German presence makes this a relevant, if not fully quantified, linkage for investors tracking margin and supply-chain cost impacts.

Policy Event Date: 2025-09-25

The Federal Register notice implementing the US-EU framework agreement lowers tariff-related elements on automobiles and automobile parts under Proclamation 10908, a high-severity policy shift given the scale of transatlantic auto trade. Lear Corporation's 10-K discloses that its connection systems (vehicle electronics) are manufactured in Germany, among other countries, making the company's European auto parts supply chain directly exposed to changes in US-EU auto tariff treatment. While this is a tariff decrease rather than an increase, it still signals active regulatory change in the exact trade lane—automobiles and auto parts between the EU and US—that underpins Lear's German manufacturing footprint. This matters for investors because shifts in reciprocal tariff terms can affect the cost competitiveness and margin profile of Lear's Germany-based electronics production as it flows into US-bound vehicles, even though the immediate effect here is tariff relief rather than new cost burden.

Policy Event Date: 2025-09-25

The Federal Register notice describes a US-EU reciprocal tariff framework that adjusts (decreases) tariffs on automobiles and automobile parts previously subject to Proclamation 10908. Tesla's 10-K discloses that its Germany manufacturing facility exists specifically to reduce transportation and manufacturing costs and to limit exposure to unfavorable tariffs, alongside its China plant, for serving local markets. Because Tesla explicitly frames its German plant as a tariff-mitigation strategy, a change in US-EU auto tariff terms per the Federal Register document directly touches the cost-benefit logic Tesla lays out in its own risk disclosure. A tariff decrease could reduce the relative advantage of local EU production versus exporting from other regions, altering the calculus Tesla itself flags. Severity is medium: the policy shift is rated high by the Policy Agent, but the filing describes a strategic rationale rather than a quantified financial exposure, so the direct financial impact on Tesla is inferred rather than stated.

Policy Event Date: 2026-08-24

The Federal Register notice describes a temporary suspension of additional duties meant to offset Canadian discrimination against U.S. commerce, specifically covering motor vehicles, and is flagged as high severity by the Policy Agent. BorgWarner's 10-K discloses that approximately 9% of its sourcing originated in Canada, showing the company has a tangible, quantified exposure to Canadian supply for auto parts. While this policy move is a tariff decrease rather than an increase—generally easing cost pressure rather than adding it—it directly touches the same trade lane (Canada-U.S. automotive trade) that BorgWarner's own risk disclosure highlights as material to its supply chain. This makes it worth monitoring: a reduction in duties could lower input costs or signal further shifts in the bilateral trade relationship, but any reversal or renegotiation of these tariff terms would directly affect the ~9% of BorgWarner's sourcing tied to Canada. Given the moderate but non-trivial size of this exposure and the fact that the policy explicitly targets motor vehicles (the same industry BorgWarner supplies into), this pairing warrants a medium severity rating—material enough to track, but not an acute risk given the tariff is decreasing rather than escalating.

Policy Event Date: 2026-08-24

The Federal Register notice describes a temporary suspension of additional duties aimed at offsetting Canadian discrimination against U.S. commerce, specifically covering motor vehicles. This is a tariff-decrease event, which reduces cross-border cost pressure rather than adding to it. GM's 10-K explicitly discloses exposure to this exact channel, noting that in 2025 the U.S. and other governments implemented new import tariffs affecting GM and its suppliers on vehicles and parts moving under the U.S.-Mexico-Canada Agreement (USMCA). Because GM's own risk disclosure already flags Canada-linked auto/parts tariffs as a cost and supply-chain risk, this suspension of additional duties directly relieves part of the burden GM itself identified. Given the high severity assigned to the policy change and GM's direct, named dependency on Canada-U.S. auto trade flows, this pairing is material but favorable — a policy easing that should modestly reduce tariff-related cost risk for GM's North American vehicle and parts network. Severity is set to medium because while the linkage is direct and well-documented in both sources, the event is a cost relief rather than a new risk, and the filing does not quantify the dollar impact.

Policy Event Date: 2026-08-24

The Federal Register notice announces a temporary suspension of additional duties aimed at offsetting Canadian discrimination against U.S. motor vehicle commerce, effectively lowering tariff friction on automobiles tied to Canada. Lear Corporation's 10-K explicitly names Canada among the countries where it sources materials or components, including automobile parts, alongside China and Mexico. While the policy targets motor vehicles rather than parts directly, the auto supply chain between the U.S. and Canada is highly integrated, so a reduction in tariff barriers on the vehicle side can ease broader cross-border cost pressures relevant to Lear's Canadian-linked component sourcing. Because the filing confirms Canada is a material node in Lear's supply chain but the policy's direct scope (vehicles, not parts) doesn't perfectly match the disclosed risk (parts/components), this is flagged as a favorable but only moderately direct read-through for portfolio risk monitoring.

Policy Event Date: 2026-04-23

The Federal Register notice describes a new procedure letting the Secretary of Commerce reduce Section 232 tariffs owed under Proclamations 9704 and 9705 for steel and aluminum producers with production facilities in Canada or Mexico. This is a high-severity regulatory change because it directly alters the competitive tariff landscape for aluminum producers operating in North America. Alcoa's 10-K discloses US-based aluminum production capacity at its Massena West, NY and Evansville, IN (Warrick) facilities, confirming Alcoa's operations are concentrated domestically rather than in Canada or Mexico. As a result, if Canadian or Mexican producers gain reduced tariff burdens per this policy, Alcoa's US-based facilities would not benefit from the same relief, potentially disadvantaging its cost position relative to North American peers with cross-border operations. The filing does not detail Alcoa's Canadian or Mexican footprint in this excerpt, so the direct impact on Alcoa's own tariff exposure is not fully confirmed, warranting a medium severity rating pending further disclosure.

Policy Event Date: 2025-08-29

The Federal Register notice confirms a final affirmative determination that certain corrosion-resistant steel products (CORE) from Canada are being sold in the US at less than fair value, an import restriction action targeting steel coil and sheet trade between the two countries. Nucor's 10-K explicitly discloses that its steel mills segment sells products throughout the United States, Canada and Mexico, confirming Canada is a material market for its steel trade flows. While Nucor's filing does not specify CORE products directly, the cross-border sales exposure it discloses means any US trade action affecting Canadian steel imports could influence competitive dynamics, pricing, or market access in the region Nucor already identifies as core to its steel mills segment. Given the medium severity of the policy action and the general (not product-specific) nature of Nucor's disclosed Canada exposure, this warrants monitoring but not immediate alarm.

Policy Event Date: 2025-08-29

The Federal Register notice confirms a final affirmative determination that certain corrosion-resistant steel products (CORE) from Canada are being sold in the US at less than fair value, an import restriction likely to trigger duties on Canadian steel coil and sheet. Reliance's 10-K already discloses exposure to Canada-related trade policy risk, noting that executive orders directed increased tariffs on imports from Canada, Mexico and China, with threats of further escalation. Because Reliance sources steel and aluminum with cross-border ties to Canada, this new anti-dumping determination compounds the tariff risk the company has already flagged, potentially raising input costs or disrupting supply for CORE-related products even though the filing does not quantify the exposure.

Policy Event Date: 2025-08-29

The Federal Register notice confirms a final affirmative determination that corrosion-resistant steel products (CORE), including steel coil and sheet, from Canada are being sold at less than fair value, which typically leads to antidumping duties or trade remedies affecting Canadian steel exports to the U.S. Worthington Steel's 10-K discloses that it operates 2 manufacturing facilities in Canada as part of its broader footprint spanning the U.S., China, India, Germany, and Mexico. While the filing does not specify Canadian output volumes or direct exposure to CORE products, the presence of Canadian operations means any new trade barriers or duties on Canadian steel coil and sheet flows could affect input costs, cross-border logistics, or competitive dynamics for Worthington's Canadian facilities. Given the direct commodity and country match but the lack of explicit detail in the filing about Canada-specific product lines or trade dependency, this warrants medium-severity attention as a potential but not fully confirmed operational risk.

Policy Event Date: 2025-04-10

Commerce's preliminary affirmative dumping determination on corrosion-resistant steel products from Canada, per the Federal Register notice, signals potential trade friction and pricing/duty exposure in the North American corrosion-resistant steel market. Nucor's 10-K discloses that its steel mills segment sells products throughout the United States, Canada and Mexico, meaning cross-border trade actions like this one could affect the competitive dynamics and pricing environment in which Nucor operates. While the filing does not specify CORE products explicitly, the direct geographic overlap with Canada and the steel commodity match warrant monitoring, as any resulting duties or retaliatory trade measures could influence Nucor's regional sales flows or competitive positioning versus Canadian producers.

Policy Event Date: 2025-04-10

Commerce has preliminarily determined that corrosion-resistant steel products from Canada are being sold at less than fair value, per the Federal Register notice, a finding that typically leads to antidumping duties on Canadian steel coil and sheet imports. This adds a new, more product-specific trade risk on top of the broader tariff exposure Reliance (RS) already discloses: as Reliance's 10-K notes, the White House issued executive orders in February 2025 directing increased tariffs on imports from Canada, Mexico and China, with threats of further escalation if countries retaliate. Together, these developments signal that Canadian steel sourcing is facing compounding cost pressure from both antidumping action and broader tariff policy, which is directly relevant to Reliance's supply chain given its acknowledged reliance on Canadian steel and aluminum imports. The severity is medium because while the Commerce determination is only preliminary and specific to corrosion-resistant steel, it reinforces and sharpens a risk Reliance has already flagged as material to its business.

Policy Event Date: 2025-04-10

Commerce's preliminary determination, per the Federal Register notice, finds that corrosion-resistant steel products from Canada are being sold at less than fair value — a step that typically precedes anti-dumping duties on steel coil and sheet trade tied to Canada. Worthington Steel's 10-K discloses that it operates 2 manufacturing facilities in Canada as part of its broader footprint, confirming direct operational exposure to Canadian steel production and trade flows. While the filing does not break out Canada-specific revenue or detail cross-border shipment volumes, the geographic overlap means any resulting tariffs or trade friction from this proceeding could affect input costs, intercompany transfers, or competitiveness of Worthington's Canadian operations. Given the medium severity of the policy action and the fact that Worthington's own risk disclosure explicitly confirms Canadian manufacturing presence, this pairing warrants monitoring but not yet urgent escalation.

Policy Event Date: 2025-02-10

The U.S. Commerce Department has preliminarily found that countervailable subsidies are being provided to producers and exporters of corrosion-resistant steel products from Canada, per the Federal Register notice dated 2025-02-10. This is significant because Nucor's 10-K discloses that its steel mills segment sells products across the United States, Canada, and Mexico, indicating meaningful commercial exposure to the Canadian steel market. While the filing does not specify volumes or the exact products involved, any countervailing duty action affecting steel trade with Canada could impact the competitive dynamics or pricing environment in which Nucor's Canada-facing sales operate. Given that the policy action is still at the preliminary stage and the filing reference is a general market disclosure rather than a specific risk factor tied to CORE products, the direct materiality to Nucor is not fully confirmed, warranting a medium severity rating.

Policy Event Date: 2025-02-10

Commerce's preliminary countervailing duty determination on corrosion-resistant steel products from Canada, per the Federal Register notice, adds a new trade barrier on Canadian steel coil and sheet just as Reliance (RS) already warns investors about escalating cross-border trade risk. As Reliance's 10-K discloses, the White House's February 1, 2025 executive orders directing increased tariffs on imports from Canada (among other countries) are a live risk factor for the company. The new countervailing duty finding on Canadian CORE steel reinforces and adds to that same Canada-sourcing exposure the filing already flags, suggesting Reliance's supply costs and sourcing decisions for steel products from Canada could face compounding pressure from both the tariff actions and this separate trade remedy action.

Policy Event Date: 2025-02-10

Commerce's preliminary countervailing duty determination on corrosion-resistant steel products from Canada, per the Federal Register notice, signals that Canadian steel coil and sheet producers/exporters may soon face duties on this trade lane. Worthington Steel's 10-K discloses it operates 2 manufacturing facilities in Canada as part of its steel coil and sheet operations, meaning any cross-border sourcing or sales tied to those facilities could be directly exposed to the new duty regime. While the filing does not quantify the exposure or confirm intra-company cross-border flows, the geographic overlap between the CVD action and Worthington's disclosed Canadian footprint in the same commodity warrants monitoring for potential cost or supply-chain impact.

Policy Event Date: 2026-06-04

The Federal Register notice (June 2026) confirms the U.S. government is further raising tariff regimes on imports of aluminum, steel, and copper, a high-severity trade policy shift. Alcoa's 10-K explicitly lists U.S.-based aluminum production sites, including Massena West, NY and Evansville, IN (Warrick), showing the company operates significant domestic aluminum smelting capacity in the country directly affected by this tariff action. While tariffs on imports could benefit domestic producers like Alcoa by making foreign aluminum more expensive, they also raise the stakes for input costs, trade retaliation risk, and downstream demand shifts tied to U.S. aluminum policy. Because Alcoa's own filing confirms concentrated U.S. production footprint in the same commodity and country named in the policy, this pairing is a direct, material match worth monitoring for cost and competitive impact, though the filing text itself does not detail specific financial exposure.

Policy Event Date: 2025-09-17

The Federal Register notice announces the opening of the September 2025 inclusions window for the Section 232 steel and aluminum tariff program, meaning additional derivative products could be added to tariff coverage on US aluminum. Alcoa's 10-K discloses significant US-based aluminum operations, specifically listing capacity at its Massena West, NY and Evansville, IN (Warrick) facilities. Because Alcoa's own filing confirms material domestic aluminum production tied directly to the commodity and country named in the policy notice, any expansion of tariff scope through this inclusions process could affect input costs, product classifications, or competitive dynamics for these specific facilities. The direct overlap between the policy's commodity/country scope and Alcoa's disclosed US aluminum asset base makes this a relevant, though not yet certain, exposure—warranting monitoring as the inclusions window progresses, without yet representing a confirmed material impact.

Policy Event Date: 2026-04-29

The Federal Register notice describes a regulatory action strengthening measures to adjust imports of aluminum, steel, and copper into the United States on national-security grounds, per the policy source. Alcoa's 10-K discloses significant domestic aluminum production capacity at its Massena West, NY and Warrick, IN facilities, confirming the company operates material US-based aluminum assets that fall within the scope of this policy area. While the filing text is a facility/capacity listing rather than an explicit risk discussion, the direct overlap in country (United States) and commodity (aluminum) means any tightening of import adjustment mechanisms could affect input costs, competitive dynamics, or downstream demand for Alcoa's US smelting operations. Given the policy is a technical/regulatory adjustment rather than a new tariff rate hike, and the filing reference is descriptive rather than risk-specific, this warrants medium attention rather than urgent action.

Policy Event Date: 2024-05-20

The Federal Register final rule (effective 2024-05-20) revises how companies can request exclusions from Section 232 duties and quantitative limits on steel and aluminum imports into the United States. Alcoa's 10-K explicitly discloses U.S.-based aluminum production facilities, including Massena West, NY and Evansville, IN (Warrick), confirming that Alcoa operates domestic aluminum assets directly exposed to U.S. trade policy on this commodity. While the risk text does not detail import dependencies, any changes to the Section 232 exclusion process can alter competitive dynamics, input costs, or trade flows for aluminum in the U.S. market where Alcoa maintains significant operations. Given the medium severity of the regulatory change and the clear commodity/country match with Alcoa's disclosed facilities, portfolio managers should monitor how revised exclusion procedures might indirectly affect Alcoa's cost structure or market positioning, even though the filing does not specify direct import reliance.

Policy Event Date: 2026-08-06

The Federal Register notice describes a proposal to add 14 additional derivative articles to Section 232 duties on steel, aluminum, and copper, per the federal register filing dated 2026-08-06. Alcoa's 10-K discloses significant US aluminum operations, specifically listing its Massena West, NY and Evansville, IN (Warrick) facilities with production capacity figures, confirming the company's direct exposure to US aluminum production and trade policy. Because Alcoa manufactures aluminum domestically, any expansion of Section 232 duties on aluminum derivative products could affect input costs, downstream customer demand, or competitive dynamics for products made at these facilities. While the policy is still in a public comment/proposal stage rather than finalized, the direct commodity and geographic overlap between the tariff proposal and Alcoa's disclosed US aluminum footprint warrants monitoring by portfolio managers tracking metals-sector tariff risk.

Policy Event Date: 2025-06-16

Per the Federal Register notice, the US President imposed new duties on steel imports and BIS expanded Annex 1 to cover additional steel derivative products effective June 16, 2025 — a high-severity trade action from the Policy Agent's assessment. While the tariff targets steel rather than aluminum directly, it signals an active, escalating US posture on metals trade policy that raises the risk of parallel or follow-on measures affecting aluminum. Alcoa's 10-K discloses significant US-based operations, including its Massena West, NY and Warrick, IN facilities, confirming meaningful domestic production exposure. Any broadening of US metals tariff actions — as this steel proclamation demonstrates is plausible — could affect input costs, trade flows, or retaliatory dynamics relevant to Alcoa's US aluminum operations. Given the tariff action is on a related but distinct commodity, and the filing is a general facility listing rather than a specific tariff risk disclosure, the direct linkage is moderate rather than high.